Cleveland BioLabs Inc. | Ownership
Companies that own Cleveland BioLabs Inc.
Renaissance Technologies LLC
269,116
2.38%
9,500
0%
06/30/2018
The Vanguard Group, Inc.
170,347
1.51%
0
0%
06/30/2018
G1 Execution Services LLC
25,982
0.23%
13,995
0%
06/30/2018
Geode Capital Management LLC
16,688
0.15%
0
0%
06/30/2018
Citadel Advisors LLC
15,389
0.14%
1,888
0%
06/30/2018
BlackRock Fund Advisors
13,430
0.12%
2,548
0%
06/30/2018
UBS Securities LLC
1,370
0.01%
-2,560
0%
06/30/2018
BlackRock Investment Management LLC
775
0.01%
0
0%
06/30/2018
IFP Advisors, Inc.
150
0%
-250
0%
06/30/2018
Wells Fargo Clearing Services LLC
150
0%
50
0%
06/30/2018
| Address |
73 High Street
Buffalo New York 14203
United States
|
|
Employees
|
- |
| Website |
http://www.cbiolabs.com |
| Updated |
07/08/2019 |
| Cleveland BioLabs, Inc. is a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. |
